Literature DB >> 17499207

Clinical features associated with an Asp380His Myocilin mutation in a US family with primary open-angle glaucoma.

Mary K Wirtz1, John R Samples, Dongseok Choi, N Donna Gaudette.   

Abstract

PURPOSE: To determine the glaucoma phenotype of an American pedigree with the myocilin Asp380His.
DESIGN: An observational case series study.
METHODS: An observational case series study was used to examine a family in which an Asp380His myocilin mutation was segregating. Thirteen family members were examined and medical records were obtained on the remaining two individuals. Blood samples were collected from all 15 participants following the tenets of the Helsinki declaration under the auspices of the Oregon Health & Sciences University Institutional Review Board and screened for myocilin variants by denaturing high-performance liquid chromatography (dHPLC). Any DNA samples with dHPLC data different from the control sample were sequenced for base pair analysis.
RESULTS: An Asp380His myocilin mutation was identified in eight members, seven of whom had primary open-angle glaucoma (POAG). The eighth individual had high intraocular pressures (IOPs). The disease presents in this family with extremely high IOPs requiring trabeculectomies to control the pressure. The age at diagnosis ranged from 30 to 45.
CONCLUSIONS: This family with an Asp380His myocilin mutation presents with an intermediate phenotype between juvenile- and adult-onset glaucoma. The Asp380 amino acid residue appears to be important in myocilin function based on the finding that substitution of this amino acid with four different amino acids (His, Ala, Asn, or Gly) all result in a similar presentation of POAG that is intermediate between the more severe clinical presentations observed in individuals with the Pro370Leu or Lys423Glu variant and the milder findings in patients with the Gln368Stop mutation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17499207      PMCID: PMC1948101          DOI: 10.1016/j.ajo.2007.03.037

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  52 in total

1.  Novel TIGR sequence alteration Val53Ala.

Authors:  C P Pang; Y F Leung; J K Chua; L Baum; D S Fan; D S Lam
Journal:  Hum Mutat       Date:  2000-01       Impact factor: 4.878

2.  Novel mutations in the myocilin gene in Japanese glaucoma patients.

Authors:  R Kubota; Y Mashima; Y Ohtake; T Tanino; T Kimura; Y Hotta; A Kanai; S Tokuoka; I Azuma; H Tanihara; M Inatani; Y Inoue; J Kudoh; Y Oguchi; N Shimizu
Journal:  Hum Mutat       Date:  2000-09       Impact factor: 4.878

3.  Mutations in the third exon of the MYOC gene in spanish patients with primary open angle glaucoma.

Authors:  C M Vázquez; O M Herrero; B M Bastús; V D Pérez
Journal:  Ophthalmic Genet       Date:  2000-06       Impact factor: 1.803

4.  Age-dependent prevalence of mutations at the GLC1A locus in primary open-angle glaucoma.

Authors:  S Shimizu; P R Lichter; A T Johnson; Z Zhou; M Higashi; M Gottfredsdottir; M Othman; S E Moroi; F W Rozsa; R M Schertzer; M S Clarke; A L Schwartz; C A Downs; D Vollrath; J E Richards
Journal:  Am J Ophthalmol       Date:  2000-08       Impact factor: 5.258

5.  Evidence for genetic heterogeneity within eight glaucoma families, with the GLC1A Gln368STOP mutation being an important phenotypic modifier.

Authors:  J E Craig; P N Baird; D L Healey; A I McNaught; P J McCartney; J L Rait; J L Dickinson; L Roe; J H Fingert; E M Stone; D A Mackey
Journal:  Ophthalmology       Date:  2001-09       Impact factor: 12.079

6.  The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma.

Authors:  Mae O Gordon; Julia A Beiser; James D Brandt; Dale K Heuer; Eve J Higginbotham; Chris A Johnson; John L Keltner; J Philip Miller; Richard K Parrish; M Roy Wilson; Michael A Kass
Journal:  Arch Ophthalmol       Date:  2002-06

7.  Digenic inheritance of early-onset glaucoma: CYP1B1, a potential modifier gene.

Authors:  Andrea L Vincent; Gail Billingsley; Yvonne Buys; Alex V Levin; Megan Priston; Graham Trope; Donna Williams-Lyn; Elise Héon
Journal:  Am J Hum Genet       Date:  2002-01-03       Impact factor: 11.025

8.  TIGR/MYOC gene sequence alterations in individuals with and without primary open-angle glaucoma.

Authors:  Chi Pui Pang; Yuk Fai Leung; Baojian Fan; Larry Baum; Win Chi Tong; Wing Shan Lee; John K H Chua; Dorothy S P Fan; Yao Liu; Dennis S C Lam
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-10       Impact factor: 4.799

9.  Functional analysis of the glaucoma-causing TIGR/myocilin protein: integrity of amino-terminal coiled-coil regions and olfactomedin homology domain is essential for extracellular adhesion and secretion.

Authors:  Stéphane Gobeil; Laurence Letartre; Vincent Raymond
Journal:  Exp Eye Res       Date:  2006-02-08       Impact factor: 3.467

10.  Founder TIGR/myocilin mutations for glaucoma in the Québec population.

Authors:  Mathieu Faucher; Jean-Louis Anctil; Marc-André Rodrigue; Annie Duchesne; Dan Bergeron; Pierre Blondeau; Gilles Côté; Stéphane Dubois; Josée Bergeron; Rose Arseneault; Jean Morissette; Vincent Raymond
Journal:  Hum Mol Genet       Date:  2002-09-01       Impact factor: 6.150

View more
  8 in total

Review 1.  The effects of myocilin expression on functionally relevant trabecular meshwork genes: a mini-review.

Authors:  Teresa Borrás
Journal:  J Ocul Pharmacol Ther       Date:  2014-02-24       Impact factor: 2.671

2.  Association of POAG risk factors and the Thr377Met MYOC mutation in an isolated Greek population.

Authors:  Mary K Wirtz; John R Samples; Victoria Toumanidou; Jac Charlesworth; Dimitrios G Mikropoulos; Konstantinos Kaltsos; Athanasios Economou; Antonios Dimopoulos; Irene N Georgiadou; Georgios Moumtzis; Athanasios Papanastasiou; Patricia L Kramer; Tom Dyer; John Blangero; Anastasios G P Konstas
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-27       Impact factor: 4.799

3.  Identification a novel MYOC gene mutation in a Chinese family with juvenile-onset open angle glaucoma.

Authors:  Xin Zhao; Chaoshan Yang; Yi Tong; Xiaohui Zhang; Liang Xu; Yang Li
Journal:  Mol Vis       Date:  2010-08-25       Impact factor: 2.367

4.  Cystatin a, a potential common link for mutant myocilin causative glaucoma.

Authors:  K David Kennedy; S A AnithaChristy; Lakisha K Buie; Teresa Borrás
Journal:  PLoS One       Date:  2012-05-15       Impact factor: 3.240

Review 5.  Common and rare myocilin variants: Predicting glaucoma pathogenicity based on genetics, clinical, and laboratory misfolding data.

Authors:  Hailee F Scelsi; Brett M Barlow; Emily G Saccuzzo; Raquel L Lieberman
Journal:  Hum Mutat       Date:  2021-06-24       Impact factor: 4.700

6.  The novel Y371D myocilin mutation causes an aggressive form of juvenile open-angle glaucoma in a Caucasian family from the Middle-East.

Authors:  Inbal Avisar; Moshe Lusky; Anat Robinson; Mordechai Shohat; Stéphane Dubois; Vincent Raymond; Dan D Gaton
Journal:  Mol Vis       Date:  2009-09-24       Impact factor: 2.367

7.  Myocilin variations and familial glaucoma in Taxiarchis, a small Greek village.

Authors:  Mary K Wirtz; Anastasios G P Konstas; John R Samples; Kostantinos Kaltsos; Athanasios Economou; Antonios Dimopoulos; Irene Georgiadou; Michael B Petersen
Journal:  Mol Vis       Date:  2008-04-25       Impact factor: 2.367

8.  A novel single nucleotide polymorphism in exon 3 of MYOC enhances the risk of glaucoma.

Authors:  Sabeen Nazir; Maryam Mukhtar; Maryam Shahnawaz; Shaima Farooqi; Naz Fatima; Rabia Mehmood; Nadeem Sheikh
Journal:  PLoS One       Date:  2018-04-09       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.